Protocol Ledger

NCT04045665 · Phase III · RECRUITING

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

Interventional Phase III clinical trial protocol NCT04045665 sponsored by Icahn School of Medicine at Mount Sinai in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2019-12-13 Enrollment: 3,200 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT04045665
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)3,200 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04045665
Protocol FieldVerified Registry Value
NCT IdentifierNCT04045665
Consolidated Lead SponsorIcahn School of Medicine at Mount Sinai
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment3,200 participants (ESTIMATED)
Registered Start Date2019-12-13
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Mount Sinai Health System across sibling Meru public-data platforms.

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI